Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies

Cancer
Norman E BreslowDaniel M Green

Abstract

After randomized trials in the 1980s, doxorubicin (DOX) was added to dactinomycin plus vincristine as standard chemotherapy for patients who had Stage III Wilms tumor (WT) of favorable histology (FH). Double-agent chemotherapy was retained for patients with Stage II disease. In this study, the authors reevaluated the efficacy of DOX using extended follow-up and additional patients. The relative risks (RR) (DOX vs. no DOX) of disease recurrence and mortality were estimated for patients with Stage II-III/FH WT who were enrolled in the third and fourth National Wilms Tumor Studies (NWTS-3 and NWTS-4). The risk of congestive heart failure (CHF) was estimated for all patients who received DOX. No statistically significant effects of DOX were found for patients with Stage II tumors. For patients with Stage III tumors, the 8 year recurrence-free survival (RFS) and overall survival (OS) rates for randomized patients on NWTS-3 were 84% and 89%, respectively, for patients who received DOX (n = 130) and 74% and 83%, respectively, for patients who did not receive DOX (n = 118). Including all patients with Stage III disease who received DOX (n = 678) and did not receive DOX (n = 138), the RRs of recurrence were 0.47 (P = 0.007) and 0.40 (P ...Continue Reading

Citations

Oct 22, 2010·Pediatric Surgery International·Shipra AgarwalKusum Verma
Oct 7, 2008·Nature Clinical Practice. Urology·Geoffrey Sonn, Linda M D Shortliffe
Jan 1, 2009·BMJ Case Reports·Philip LampteySusumu Inoue
Feb 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chiang-Ching HuangElizabeth J Perlman
Jan 12, 2008·Nephron. Clinical Practice·Ali Varan
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm A SmithGregory H Reaman
Feb 24, 2010·Journal of Indian Association of Pediatric Surgeons·Sushmita Bhatnagar
Feb 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter F EhrlichRobert C Shamberger
Jun 2, 2005·Current Opinion in Urology·Hsi-Yang WuGiulio J D'Angio
Feb 1, 2006·Expert Review of Anticancer Therapy·Filippo Spreafico, Franca Fossati Bellani
Jan 24, 2016·Hematology/oncology and Stem Cell Therapy·Wissam RabehRaya Saab
Dec 12, 2012·Journal of Pediatric Surgery·Takeshi AobaHiroaki Kitagawa
Jul 24, 2012·International Journal of Radiation Oncology, Biology, Physics·John A KalapurakalMahesh Gopalakrishnan
Nov 16, 2010·International Journal of Radiation Oncology, Biology, Physics·Filippo SpreaficoUNKNOWN AIEOP Wilms Tumor Working Group
Sep 10, 2008·Journal of Pediatric Surgery·Hart Isaacs
Sep 11, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daniel M Green
Sep 2, 2011·Genes, Chromosomes & Cancer·Richard D WilliamsKathy Pritchard-Jones
Dec 21, 2012·Pediatric Blood & Cancer·Jeffrey S DomeUNKNOWN COG Renal Tumors Committee
Sep 6, 2006·Journal of Pediatric Surgery·Sachiyo SuitaUNKNOWN Committee for pediatric solid malignant tumors in the Kyushu area
Mar 18, 2006·International Journal of Radiation Oncology, Biology, Physics·Norman E BreslowDaniel M Green
Jul 17, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Norbert GrafJan de Kraker
Jun 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zsofia KovacsMichele Bernasconi
Jul 6, 2016·Journal of Pediatric Hematology/oncology·Constanza CafferataPedro Zubizarreta
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S DomeKathy Pritchard-Jones
Jun 29, 2017·The Journal of Urology·Filippo SpreaficoUNKNOWN AIEOP Wilms Tumor Working Group
Nov 2, 2017·Nature Reviews. Urology·Marry M van den Heuvel-EibrinkUNKNOWN International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG)
Sep 5, 2014·The Cochrane Database of Systematic Reviews·Elvira C van DalenLeontien C M Kremer
Nov 30, 2005·The Oncologist·Monika L Metzger, Jeffrey S Dome
Feb 1, 2018·Oncotarget·Lourdes Hontecillas-PrietoEnrique de Álava
Apr 23, 2017·Pediatric Surgery International·Md Nahidul WariAmit Dinda
Aug 10, 2019·Pediatric Surgery International·Takaharu OueUNKNOWN Renal tumor Committee of the Japanese Children’s Cancer Group
Oct 6, 2020·Journal of Biochemical and Molecular Toxicology·Rania SalahEl-Said El-Sherbini
Jul 3, 2021·Cancers·Alissa GroenendijkAnnelies M C Mavinkurve-Groothuis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.